Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

When to start antiretroviral therapy.

Rhame FS.

Curr Infect Dis Rep. 2011 Feb;13(1):60-7. doi: 10.1007/s11908-010-0154-8.

PMID:
21308456
2.

HIV subtype, epidemiological and mutational correlations in patients from Paraná, Brazil.

Silva MM, Telles FQ, da Cunha CA, Rhame FS.

Braz J Infect Dis. 2010 Sep-Oct;14(5):495-501.

3.

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G Jr, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC Jr, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL Jr, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC 3rd, Olender SA, Ostrowski M, Owen WF Jr, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC 3rd, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM Jr, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M.

Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.

4.

Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

Lifson AR; INSIGHT Endpoint Review Committee Writing Group, Belloso WH, Davey RT, Duprez D, Gatell JM, Hoy JF, Krum EA, Nelson R, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson JH, Worley J, INSIGHT Study Group.

HIV Clin Trials. 2010 Jul-Aug;11(4):205-19. doi: 10.1310/hct1104-205.

5.

Integrating HIV-related evidence-based renal care guidelines into adult HIV clinics.

Goodroad BK, Wright T, Rhame FS.

J Assoc Nurses AIDS Care. 2010 Mar-Apr;21(2):113-24. doi: 10.1016/j.jana.2009.11.001. Epub 2010 Jan 29.

PMID:
20116297
6.

Determination of the underlying cause of death in three multicenter international HIV clinical trials.

Lifson AR; INSIGHT Cause of Death Writing Group, Belloso WH, Carey C, Davey RT, Duprez D, El-Sadr WM, Gatell JM, Gey DC, Hoy JF, Krum EA, Nelson R, Nixon DE, Paton N, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson J, Worley J.

HIV Clin Trials. 2008 May-Jun;9(3):177-85. doi: 10.1310/hct0903-177.

7.

Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials.

Lifson AR, Rhame FS, Belloso WH, Dragsted UB, El-Sadr WM, Gatell JM, Hoy JF, Krum EA, Nelson R, Pedersen C, Pett SL, Davey RT Jr.

HIV Clin Trials. 2006 May-Jun;7(3):125-41.

PMID:
16880169
8.
9.

Uncertain generalizability of switch studies.

Rhame FS.

Clin Infect Dis. 2003 Apr 15;36(8):1089. No abstract available.

PMID:
12684930
10.

Quantifying and documenting prior beliefs in clinical trials.

Chaloner K, Rhame FS.

Stat Med. 2001 Feb 28;20(4):581-600.

PMID:
11223902
11.

Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.

Kakuda TN, Page LM, Anderson PL, Henry K, Schacker TW, Rhame FS, Acosta EP, Brundage RC, Fletcher CV.

Antimicrob Agents Chemother. 2001 Jan;45(1):236-42.

12.

Implications of "market baskets," a pharmaceutical marketing practice.

Rhame FS.

JAMA. 1999 Sep 22-29;282(12):1134. No abstract available.

PMID:
10501115
13.

Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.

Green LA, Rhame FS, Price RW, Perlman DC, Capps LG, Sampson JH, Deyton LR, Schnittman SM, Fisher EJ, Bartsch GE, Krum EA, Neaton JD.

AIDS. 1998 Oct 22;12(15):1983-90.

PMID:
9814866
14.

Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS.

Fletcher CV, Goodroad BK, Cummins LM, Henry K, Balfour HH Jr, Rhame FS.

Antimicrob Agents Chemother. 1997 Jul;41(7):1571-4.

15.

Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.

Michalová K, Moyes AL, Cameron S, Juni BA, Obritsch WF, Dvorak JA, Doughman DJ, Rhame FS.

Cornea. 1996 Sep;15(5):533-6.

PMID:
8862931
16.

Strategies for control of zidovudine concentrations in serum.

Noormohamed SE, Henry WK, Rhame FS, Balfour HH Jr, Fletcher CV.

Antimicrob Agents Chemother. 1995 Dec;39(12):2792-7.

17.

The effect of cimetidine and ranitidine administration with zidovudine.

Fletcher CV, Henry WK, Noormohamed SE, Rhame FS, Balfour HH Jr.

Pharmacotherapy. 1995 Nov-Dec;15(6):701-8.

PMID:
8602376
18.

FDA labeling requirements for disinfection of endoscopes: a counterpoint.

Rhame FS.

Infect Control Hosp Epidemiol. 1995 Sep;16(9):497; author reply 497-8. No abstract available.

PMID:
8537624
19.

Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients.

Wells CL, Juni BA, Cameron SB, Mason KR, Dunn DL, Ferrieri P, Rhame FS.

Clin Infect Dis. 1995 Jul;21(1):45-50.

PMID:
7578758
20.

Methicillin-resistant Staphylococcus aureus.

Rhame FS.

Am J Med. 1995 Jun;98(6):599-600. No abstract available.

PMID:
7778580
21.

Value of routine pressure monitoring system changes after 72 hours of continuous use.

O'Malley MK, Rhame FS, Cerra FB, McComb RC.

Crit Care Med. 1994 Sep;22(9):1424-30.

PMID:
8062565
22.

Prevalence of oral lesions in symptomatic and asymptomatic HIV patients.

Little JW, Melnick SL, Rhame FS, Balfour HH Jr, Decher L, Rhodus NL, Merry JW, Walker PO, Miller CE, Volberding P.

Gen Dent. 1994 Sep-Oct;42(5):446-50. No abstract available.

PMID:
7489878
23.

Foscarnet for suppression of human immunodeficiency virus replication.

Fletcher CV, Collier AC, Rhame FS, Bennett D, Para MF, Beatty CC, Jones CE, Balfour HH Jr.

Antimicrob Agents Chemother. 1994 Mar;38(3):604-7.

24.

Psychological effects of participation and nonparticipation in a placebo-controlled zidovudine clinical trial with asymptomatic human immunodeficiency virus-infected individuals.

Robiner WN, Melroe NH, Campbell S, Rhame FS, Colón E, Chung J, Reaney S.

J Acquir Immune Defic Syndr. 1993 Jul;6(7):795-808.

PMID:
8509981
25.

Preventing HIV transmission. Strategies to protect clinicians and patients.

Rhame FS.

Postgrad Med. 1992 Jun;91(8):141-4, 147-52.

PMID:
1603747
26.

Comparative pharmacokinetics of zidovudine in healthy volunteers and in patients with AIDS with and without hepatic disease.

Fletcher CV, Rhame FS, Beatty CC, Simpson M, Balfour HH Jr.

Pharmacotherapy. 1992;12(6):429-34.

PMID:
1492005
27.

A look-back investigation of patients of an HIV-infected physician. Public health implications.

Danila RN, MacDonald KL, Rhame FS, Moen ME, Reier DO, LeTourneau JC, Sheehan MK, Armstrong J, Bender ME, Osterholm MT.

N Engl J Med. 1991 Nov 14;325(20):1406-11.

28.

Periodontal status of individuals in early stages of human immunodeficiency virus infection.

Drinkard CR, Decher L, Little JW, Rhame FS, Balfour HH Jr, Rhodus NL, Merry JW, Walker PO, Miller CE, Volberding PA, et al.

Community Dent Oral Epidemiol. 1991 Oct;19(5):281-5.

PMID:
1742994
29.

Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review.

Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH Jr.

Rev Infect Dis. 1991 Jul-Aug;13(4):537-47. Review.

PMID:
1822098
30.

Prevention of nosocomial aspergillosis.

Rhame FS.

J Hosp Infect. 1991 Jun;18 Suppl A:466-72. Review.

PMID:
1679817
31.

Quantitative I-123-IMP brain SPECT and neuropsychological testing in AIDS dementia.

Kuni CC, Rhame FS, Meier MJ, Foehse MC, Loewenson RB, Lee BC, Boudreau RJ, duCret RP.

Clin Nucl Med. 1991 Mar;16(3):174-7.

PMID:
2032432
32.

Transmission of gram-negative bacilli to asthmatic children via home nebulizers.

Wexler MR, Rhame FS, Blumenthal MN, Cameron SB, Juni BA, Fish LA.

Ann Allergy. 1991 Mar;66(3):267-71.

PMID:
2006776
33.

Zidovudine after occupational exposure to the human immunodeficiency virus.

Rhame FS, Russell AL.

N Engl J Med. 1991 Jan 24;324(4):266-7. No abstract available.

PMID:
1985250
34.

Increasing CD8+ T lymphocytes predict subsequent development of intraoral lesions among individuals in the early stages of infection by the human immunodeficiency virus.

Melnick SL, Hannan P, Decher L, Little JW, Rhame FS, Balfour HH Jr, Volberding P.

J Acquir Immune Defic Syndr. 1991;4(12):1199-207.

PMID:
1682473
35.

Nosocomial transmission of respiratory syncytial virus in immunocompromised adults.

Englund JA, Anderson LJ, Rhame FS.

J Clin Microbiol. 1991 Jan;29(1):115-9.

36.

An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex.

Mildvan D, Buzas J, Armstrong D, Antoniskis D, Sacks HS, Rhame FS, Mosbach EW, Pettinelli C.

J Acquir Immune Defic Syndr. 1991;4(10):945-51.

PMID:
1890604
37.

The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma.

Wahman A, Melnick SL, Rhame FS, Potter JD.

Epidemiol Rev. 1991;13:178-99. Review.

PMID:
1765111
38.

Hospital-based routine HIV testing programs.

Rhame FS.

Infect Control Hosp Epidemiol. 1990 Dec;11(12):625-7. No abstract available.

PMID:
2273225
39.

The HIV-infected surgeon.

Rhame FS.

JAMA. 1990 Jul 25;264(4):507-8. No abstract available.

PMID:
2366284
40.

Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.

Jackson JB, Kwok SY, Sninsky JJ, Hopsicker JS, Sannerud KJ, Rhame FS, Henry K, Simpson M, Balfour HH Jr.

J Clin Microbiol. 1990 Jan;28(1):16-9.

41.

Effect of oral dextran sulfate on the mouse intestinal tract.

Wells CL, Rhame FS.

J Acquir Immune Defic Syndr. 1990;3(4):361-5.

PMID:
1690287
42.

Nosocomial aspergillosis: how much protection for which patients?

Rhame FS.

Infect Control Hosp Epidemiol. 1989 Jul;10(7):296-8. No abstract available.

PMID:
2745957
43.

The case for wider use of testing for HIV infection.

Rhame FS, Maki DG.

N Engl J Med. 1989 May 11;320(19):1248-54.

PMID:
2710203
44.

Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications.

MacDonald KL, Jackson JB, Bowman RJ, Polesky HF, Rhame FS, Balfour HH Jr, Osterholm MT.

Ann Intern Med. 1989 Apr 15;110(8):617-21.

PMID:
2648922
45.

Nosocomial adenovirus infections: molecular epidemiology of an outbreak due to adenovirus 3a.

Brummitt CF, Cherrington JM, Katzenstein DA, Juni BA, Van Drunen N, Edelman C, Rhame FS, Jordan MC.

J Infect Dis. 1988 Aug;158(2):423-32.

PMID:
2841380
46.

Mycobacterium terrae tenosynovitis.

Kremer LB, Rhame FS, House JH.

Arthritis Rheum. 1988 Jul;31(7):932-4. No abstract available.

PMID:
3395389
47.

Rapid and sensitive viral culture method for human immunodeficiency virus type 1.

Jackson JB, Coombs RW, Sannerud K, Rhame FS, Balfour HH Jr.

J Clin Microbiol. 1988 Jul;26(7):1416-8.

48.

More on "safe sex".

Rhame FS.

N Engl J Med. 1988 Jun 30;318(26):1760-1. No abstract available.

PMID:
3374548
49.

Neutropenia in an HIV-1-infected renal transplant recipient treated with zidovudine.

Erice A, Rhame FS, Dunn DL, Chinnock B, Balfour HH Jr.

JAMA. 1988 Jun 17;259(23):3407-8. No abstract available.

PMID:
3286912
50.

Evaluation of two commercial tests for human immunodeficiency virus antigens in culture supernatant fluid.

Jackson JB, Sannerud K, Rhame FS, Balfour HH Jr.

Am J Clin Pathol. 1988 Jun;89(6):788-90.

PMID:
3285660

Supplemental Content

Loading ...
Support Center